ORUKA THERAPEUTICS, INC. — Cash Flow Charts
4 quarters of history · ending 2024-06-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-2M
Free Cash Flow
$-2M
Investing Cash Flow
$0
Financing Cash Flow
$0
Capex
—
Stock-Based Comp
$654K
D&A
$3K
SBC Allocated Expense
$683K